Clinical trial
A Multicenter Single Arm Phase II Study With Bicalutamide in Combination With Abemaciclib in 4 Cohorts of Locoregionally Advanced Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer
NCT06365788 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Single Arm Phase II Study With Bicalutamide in Combination With Abemaciclib in 4 Cohorts of Locoregionally Advanced Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer
- Lead sponsor
- Universitaire Ziekenhuizen KU Leuven
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- April 8, 2024
- Completion date
- December 31, 2028
- Enrollment
- 53 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.